Literature DB >> 23639613

The end of the road for empirical antifungal treatment?

J Peter Donnelly1, Johan Maertens.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 23639613     DOI: 10.1016/S1473-3099(13)70112-9

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  4 in total

1.  Comparison of Performance Characteristics of Aspergillus PCR in Testing a Range of Blood-Based Samples in Accordance with International Methodological Recommendations.

Authors:  Jan Springer; P Lewis White; Shanna Hamilton; Denise Michel; Rosemary A Barnes; Hermann Einsele; Juergen Löffler
Journal:  J Clin Microbiol       Date:  2016-01-06       Impact factor: 5.948

2.  Predicting Invasive Aspergillosis in Hematology Patients by Combining Clinical and Genetic Risk Factors with Early Diagnostic Biomarkers.

Authors:  P Lewis White; Christian Parr; Rosemary A Barnes
Journal:  J Clin Microbiol       Date:  2017-12-26       Impact factor: 5.948

3.  Application of metagenomic next-generation sequencing in the diagnosis of pulmonary invasive fungal disease.

Authors:  Chengtan Wang; Zhiqing You; Juanjuan Fu; Shuai Chen; Di Bai; Hui Zhao; Pingping Song; Xiuqin Jia; Xiaoju Yuan; Wenbin Xu; Qigang Zhao; Feng Pang
Journal:  Front Cell Infect Microbiol       Date:  2022-09-27       Impact factor: 6.073

Review 4.  Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia.

Authors:  Monica Fung; Jane Kim; Francisco M Marty; Michaël Schwarzinger; Sophia Koo
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.